Over 14 million people in the United States will contract some form of cancer during their lifetimes. With the rising population, that number will inevitably rise drastically. However, with new technological advances being made by people like Eric Lefkofsky, who co-founded Tempus, future patients may have a more hopeful outlook.
Tempus has created technology that will streamline the care of cancer patients by maintaining and analyzing their individual medical and clinical data. The software also includes voice recognition technology that will convert spoken word into structured data that can then be analyzed to afford the best care for individual patient. When this information is combined with genome information, doctors will be able to pair patients with the best treatment options. Using this system will also allow the information to be updated in real time. For more info about us: http://chicagoinno.streetwise.co/2016/07/22/eric-lefkofskys-next-move-curing-cancer-at-tempus/ click here.
After he graduated from the University of Michigan in Ann Arbor in 1993 with a law degree, Lefkofsky got swept up by the early dot com boom and became one of the key players in that arena. He founded a number of successful Internet businesses, the most well-known being Groupon. He invested $1 million in Groupon after hearing about the idea from a former boss, Andrew Mason.
Along with his wife, Elizabeth, Lefkofsky founded the charitable trust, the Lefkofsky Foundation, which focuses on giving funds to organizations that help children. To date, the foundation as given aid to more than 50 different charities.
After his wife was diagnosed with breast cancer, Lefkofsky noticed that cancer treatment and research seemed to be behind the times. He aimed to do something about it, and hopefully to change the way cancer patients are treated using data collection and digital technology. After overcoming a few hurdles along the way, it looks as if Tempus may be doing just that.